There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| Ask | Qty | Orders |
|---|---|---|
Annual Revenue,rose 11.19%, in the last year to ₹3,268.62 Cr. Its sector's average revenue growth for the last fiscal year was 8.04%.Annual Net Profit,rose 36.79% in the last year to ₹505.5 Cr. Its sector's average net profit growth for the last fiscal year was 28.77%.Price to Earning Ratio,is 47.16, lower than its sector PE ratio of 49.77.As a leading Indian agri-inputs company Sumitomo Chemical India Limited (SCIL) delivers crop protection and biorationals alongside plant growth regulators (PGRs) and crop nutrition products alongside fumigants and rodenticides and public health solutions. The Company distributes Japanese parent Sumitomo Chemical Company Limited proprietary products through its Indian operations in the domestic agrochemicals and environment health markets and maintains Valent BioSciences distribution operations in the Indian market. The company operates through a comprehensive product range including both standard and unique formulations and maintains itself as one of India’s rare manufacturers with chemical and biological solutions. The public health business is currently smaller but strategically important.
SCIL operates five manufacturing facilities (Bhavnagar, Gajod, Tarapur, Vapi and Silvassa) and three DSIR-approved R&D labs in Mumbai, Bhavnagar and Gajod. Its network spans 60 depots, presence across 30 Indian states, and direct exports from India to 50+ countries.
The organization marked its twenty-fifth year since inception demonstrating success through innovative practices while maintaining connections with farmers and operational stability. SCIL has two subsidiaries.
The company achieved important milestones through developing its domestic brand portfolio and exporting products with the help of SCC partnerships and delivering new products to meet changing farm requirements.
– Segment/vertical mix (FY 2024-25): Generic 67 Per cent; Speciality 33 Per cent.
– Geography (FY 2024-25): Domestic 71 Per cent; International 29 Per cent.
– Dr Mukul Govindji Asher – Chairman.
– Chetan Shah – Managing Director.
– Sushil Marfatia – Executive Director.
– Dr Suresh Ramachandran – Deputy Managing Director.
– Anil Nawal – Chief Financial Officer.
– Deepika Trivedi – Company Secretary.
– Product pipeline and launches: SCIL introduced 13 new products during the last two years (4 fungicides, 6 insecticides, 1 herbicide and 2 plant growth regulators) which demonstrated customer-focused product development.
– Manufacturing expansion: The Company introduced a new product in a newly built multi-product plant and initiated commercial sale. The Company has received environmental clearance together with consent to establish its Greenfield project at Dahej and it establishes a second plant at Bhavnagar for global production needs and begins commercial operations of a newly launched SCC-innovated molecule at Tarapur.
– International business: SCIL distributes its technical and formulation products through partner networks in Latin America and North America and Asia Pacific and Africa and the Middle East and Europe by using SCC synergies to boost its global market reach.
– Corporate actions: The shareholder meeting of July 30, 2024 authorized material related-party transactions with the parent company while the Company awaits approval for transactions in FY 2025-26 exceeding Rs 7,100 Million.
– Subsidiary update: The Tanzania-based unlisted subsidiary is under voluntary winding up; this is not expected to materially impact the Company’s business or financial position.
SCIL delivers crop protection solutions including insecticides, herbicides and fungicides alongside biorationals, PGRs, crop nutrition and fumigants and rodenticides as well as public health products. The Company distributes proprietary SCC products across India and Valent BioSciences products within the domestic market.
The company operates through five manufacturing sites and three DSIR-approved research and development laboratories spread across thirty Indian states with sixty depots and exports directly to more than fifty countries. Its international network spans Latin America, North America, Asia Pacific, Africa, the Middle East and Europe.
SCIL operates two subsidiaries. The unlisted subsidiary in Tanzania continues voluntary winding up without affecting the Company's business operations or financial situation.
